OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 16, 2020
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for solid oral dosage forms.
August 05, 2020
The use of analytical assays is crucial for determining that biosimilar critical quality attributes remain on point.
August 02, 2020
Dissolution testing is an important aspect of drug development as it provides stability parameters and helps predict drug behavior in-vivo.
July 02, 2020
Real-time monitoring and the principles of quality by design were used to optimize an OSD coating process.
April 01, 2020
Tools help improve understanding of excipient risk in formulating OSD drugs.
January 02, 2020
Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.
December 15, 2019
Long a staple for quality by design and solid dosage form manufacturing, design of experiments is becoming an integral part of biopharma upstream process development.
Too narrow a focus on regulatory compliance may prevent organizations from embracing-and profiting from-quality and operational excellence.
December 02, 2019
Regulators are facing huge challenges on how to deal with the digitalization transformation occurring in the healthcare and pharmaceutical sectors.